PATENT CLAIM ANALYSIS

Application Number: 15872270
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "035000"]

Abstract:
Tunicamycin related compounds having an acyl chain double bond reduced and/or having an acyl chain double bond and an uracil ring double bond reduced are described as well as methods of making these tunicamycin related compounds. These tunicamycin related compounds are not toxic to eukaryotic cells and can be used to kill Gram-positive bacteria, alone or in combination with other antibiotics. Use of these tunicamycin related compounds to kill Gram-positive bacteria, treat Gram-positive bacterial diseases, and disinfect objects or surfaces are described. In addition, naturally-occurring streptovirudin compounds are not toxic to eukaryotic cells and can be used to kill Gram-positive bacteria, alone or in combination with other antibiotics.

Claim (Index 4):
The antibacterial composition of  claim 3 , wherein said \u03b2-lactam antibiotic is selected from the group consisting of a penicillin, a cephalosporin, a monobactam, a carbapenem, and a combination thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 2.12727
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12997429', '14888022', '14812799', '11712305', '14773603']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7919185588628358
- 35 USC 102 Novelty (BERT): 0.4986164663881956
- Combined Prediction Score: 0.7625883496153718
- Mean Citation Score: 219.37586
- Max Citation Score: 223.51625
- Similarity Product: 148.81512868203222

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test